Literature DB >> 7004659

Intestinal vascular and central hemodynamic responses in the cat following i.v. infusion of live E coli bacteria.

A Falk, B Kaijser, H E Myrvold, U Haglund.   

Abstract

Septic shock was induced in cats by i.v. infusion of live E. coli bacteria. The reactions of the series-coupled sections of the small intestinal vascular bed were followed continuously by a plethysmographic technique. Intestinal venous outflow was recorded using a drop counting technique. Intestinal venous outflow was recorded using a drop counting technique. The chest was opened and blood flow in the ascending aorta was followed electromagnetically. Pulmonary arterial blood pressure was recorded after direct cannulation. Following infusion of washed E. coli bacteria suspended in saline, a rapid early response was evident. This was characterized by arterial hypotension, unchanged aortic blood flow, pulmonary hypertension, and intestinal vasoconstriction. After 5-10 min a period of relative normalization followed. After 30-60 min a second phase, characterized by general circulatory deterioration, developed. The induced septic shock was initially characterized by a slight intestinal vasoconstriction. There was no accumulation of blood or fluid in the intestinal vascular bed; an isovolumetric state was thereby maintained in intestinal tissue throughout the experiments.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7004659

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  2 in total

1.  Changes of the Cu and Zn contents in lung and liver in intestinal ischemic reperfusion and general ischemic reperfusion in rabbits.

Authors:  Y Ming; L Yihling; H Shansheng; W Dianhuang; G Shuqing; X Zhenxing
Journal:  Biol Trace Elem Res       Date:  1993-10       Impact factor: 3.738

2.  The role of 5-hydroxytryptamine in the feline response to intravenous infusion of live E. coli.

Authors:  S Arvidsson; A Falk; E Haglind; U Haglund
Journal:  Br J Pharmacol       Date:  1983-07       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.